ProcuraAxisBeta
Sign inCreate Free Account
Home / Opportunities / Opportunity
PROCUREMENT OPPORTUNITY

NP49024 Growth Hormone

The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) · compiled

Tender information last checkedLast checked 29 Sept 2026, 19:45.

Opportunity overview

This Framework Agreement is for the supply of Growth Hormone to health boards across NHS Scotland.

Awarded to

Amounts belong to published awards or contracts. Where several suppliers share one value, it is labelled as shared and is not a supplier-specific allocation.

Merck Serono Limited

Matched by exact name
Shared contract value
£15.3m
Awarded
Not supplied
Contract signed
7 Jan 2025
Suppliers
One of 4 awarded suppliers
Award ID
000987-2025-1
Status
active
Location
Middlesex, UKI75, TW14 8HA, United Kingdom

Novo Nordisk Ltd

Matched by exact name
Shared contract value
£15.3m
Awarded
Not supplied
Contract signed
7 Jan 2025
Suppliers
One of 4 awarded suppliers
Award ID
000987-2025-1
Status
active
Location
Gatwick, UKJ, RH6 0PA, United Kingdom

Pfizer Ltd

Matched by exact name
Shared contract value
£15.3m
Awarded
Not supplied
Contract signed
7 Jan 2025
Suppliers
One of 4 awarded suppliers
Award ID
000987-2025-1
Status
active
Location
Tadworth, UK, KT20 7NS, United Kingdom

Sandoz

Match pending…
Shared contract value
£15.3m
Awarded
Not supplied
Contract signed
7 Jan 2025
Suppliers
One of 4 awarded suppliers
Award ID
000987-2025-1
Status
active
Location
Camberley, Surrey, UK, GU15 3YL, United Kingdom

Novo Nordisk Ltd

Matched by exact name
Shared contract value
£451k
Awarded
Not supplied
Contract signed
7 Jan 2025
Suppliers
One of 2 awarded suppliers
Award ID
000987-2025-2
Status
active
Location
Gatwick, UKJ, RH6 0PA, United Kingdom

Pfizer Ltd

Matched by exact name
Shared contract value
£451k
Awarded
Not supplied
Contract signed
7 Jan 2025
Suppliers
One of 2 awarded suppliers
Award ID
000987-2025-2
Status
active
Location
Tadworth, UK, KT20 7NS, United Kingdom

Classification

  • CPV33600000 — Pharmaceutical products

Lots

  • Growth Hormone Daily Dose£15.6m
  • Growth Hormone Long-Acting£450k

Published notice details

Additional information from the published procurement release. Fields appear only when supplied by the source; check the original notice and tender documents before acting.

Scope, procedure and submissions

Id
ocds-h6vhtk-049ab4
Status
complete
Has Recurrence
No
Review Details
The bringing of court proceedings against the Authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise, the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages.
Procurement Method
open
Main Procurement Category
goods
Procurement Method Details
Open procedure

Covered By

GPA

Bid Opening

Date
14 Oct 2024, 12:00

Legal basis

Id
32014L0024
Scheme
CELEX

Lot Details

Maximum Lots Bid Per Supplier
9,999,999

Techniques

Has Framework Agreement
Yes

Framework Agreement

Maximum Participants
5

Expected award period

Starts
14 Oct 2024, 12:00

Tender Period

Ends
14 Oct 2024, 12:00

Contract terms

Has Electronic Payment
Yes
Has Electronic Ordering
Yes
Electronic Invoicing Policy
allowed

Classification

Id
33600000
Scheme
CPV
Description
Pharmaceutical products

Submission terms

Languages

en

Bid Validity Period

Duration In Days
90

Submission Method

electronicSubmission

Selection criteria

Criteria

Criterion 1
Type
suitability
Description
Economic operators may be excluded from this competition if they are in breach of any situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015

Applies To

supplier
Criterion 2
Type
technical
Minimum
(a) Confirmation of existence of a valid and current UK Marketing Authorisation (PL, PLGB, PLPI number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender/start date of the Framework Agreement should be included in the Qualification Envelope of the ITT under the Technical and Professional ability: Quality Control. (b) Confirmation of the existence of valid certification of BS EN ISO 9001 or equivalent. Confirmation of such certification should be included in the Qualification Envelope of the ITT under the Quality Assurance Schemes. (c) Confirmation that samples for tendered Goods will be supplied upon request to ensure compliance with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency ("NPSA") Guidelines on Packaging and Labelling on pack design. Confirmation of sample provision should be provided in the Qualification Envelope of the ITT under Technical and Professional ability: Products. (d) A completed copy of the Bidder Climate Change Plan Template, including planned projects and actions to reduce the bidder’s carbon emissions should be provided in the Qualification Envelope of the ITT under Environmental Management Criteria. This does not need to contain calculated carbon emissions.
Description
(a) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation (PL, PLGB, or PLPI number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender/start date of the Framework Agreement. (b) Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent. (c) All tendered Goods must comply with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency ("NPSA") Guidelines on Packaging and Labelling on pack design. (d) Potential Framework Participants are required to provide evidence that their organisation has taken steps to build their awareness of the climate change emergency and how they will respond.

Applies To

supplier

Lots and requirements

Entry 1
Id
2
Title
Growth Hormone Long-Acting
Status
cancelled
Has Options
No
Has Renewal
Yes
Description
Supply of Growth Hormone (Long Acting) to NHS Scotland. The Authority has awarded this Lot as a single supplier framework per product line.

Value

Amount
450,000
Currency
GBP

Renewal

Description
This framework includes the option to extend for any number of periods, up to a maximum overall period of twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Award criteria

Criteria

Criterion 1
Name
Storage Conditions
Type
quality
Description
4
Criterion 2
Name
Homecare
Type
quality
Description
4
Criterion 3
Name
Ancillaries
Type
quality
Description
4
Criterion 4
Name
Indications
Type
quality
Description
4
Criterion 5
Name
Waste Reduction
Type
quality
Description
4
Criterion 6
Type
price
Description
80

Contract period

Duration In Days
1,080

Submission terms

Variant Policy
notAllowed
Entry 2
Id
1
Title
Growth Hormone Daily Dose
Status
cancelled
Has Options
No
Has Renewal
Yes
Description
Supply of Growth Hormone (daily dose) to NHS Scotland. The Authority has awarded this Lot as an unranked multi-supplier framework.

Value

Amount
15,550,000
Currency
GBP

Renewal

Description
This framework includes the option to extend for any number of periods, up to a maximum overall period of twelve (12) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire

Award criteria

Criteria

Criterion 1
Name
Storage Conditions
Type
quality
Description
4
Criterion 2
Name
Homecare
Type
quality
Description
4
Criterion 3
Name
Ancillaries
Type
quality
Description
4
Criterion 4
Name
Indications
Type
quality
Description
4
Criterion 5
Name
Waste Reduction
Type
quality
Description
4
Criterion 6
Type
price
Description
80

Contract period

Duration In Days
1,080

Submission terms

Variant Policy
notAllowed

Items and delivery

Item 1
Id
2
Related Lot
2

Delivery Location

Description
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.

Delivery locations

Entry 1
Region
UKM
Entry 2
Region
UKM

Additional Classifications

Entry 1
Id
33600000
Scheme
CPV
Description
Pharmaceutical products
Item 2
Id
1
Related Lot
1

Delivery Location

Description
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014

Delivery locations

Entry 1
Region
UKM
Entry 2
Region
UKM

Additional Classifications

Entry 1
Id
33600000
Scheme
CPV
Description
Pharmaceutical products

Buyer, suppliers and contacts

Organisation 1
Id
GB-FTS-115937
Name
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

Roles

buyer
centralPurchasingBody

Address

Region
UKM
Locality
Edinburgh
Postal Code
EH12 9EB
Country Name
United Kingdom
Street Address
1 South Gyle Crescent

Details

Classifications

Entry 1
Id
BODY_PUBLIC
Scheme
TED_CA_TYPE
Description
Body governed by public law
Entry 2
Id
07
Scheme
COFOG
Description
Health

Identifier

Legal Name
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

Contact

Name
Laura Ferguson
Organisation 2
Id
GB-FTS-324
Name
Sheriff Court House

Roles

reviewBody

Address

Locality
Edinburgh
Postal Code
EH1 1LB
Country Name
United Kingdom
Street Address
27 Chambers Street

Details

Identifier

Legal Name
Sheriff Court House

Contact

Telephone
+44 1312252525
Organisation 3
Id
GB-FTS-58186
Name
Merck Serono Limited

Roles

supplier

Address

Region
UKI75
Locality
Middlesex
Postal Code
TW14 8HA
Country Name
United Kingdom
Street Address
5 New Square, Bedfont Lakes Business Park , Feltham

Details

Scale
large

Identifier

Legal Name
Merck Serono Limited

Contact

Telephone
+44 7423735163
Organisation 4
Id
GB-FTS-134791
Name
Novo Nordisk Ltd

Roles

supplier

Address

Region
UKJ
Locality
Gatwick
Postal Code
RH6 0PA
Country Name
United Kingdom
Street Address
3 City Place, Beehive Ring Road

Details

Scale
large

Identifier

Legal Name
Novo Nordisk Ltd

Contact

Telephone
+44 1293762293
Organisation 5
Id
GB-FTS-57454
Name
Pfizer Ltd

Roles

supplier

Address

Region
UK
Locality
Tadworth
Postal Code
KT20 7NS
Country Name
United Kingdom
Street Address
Walton Oaks, Dorking Road

Details

Scale
large

Identifier

Legal Name
Pfizer Ltd

Contact

Telephone
+44 7471112086
Organisation 6
Id
GB-FTS-95765
Name
Sandoz

Roles

supplier

Address

Region
UK
Locality
Camberley, Surrey
Postal Code
GU15 3YL
Country Name
United Kingdom
Street Address
Park View, Riverside Way, Watchmoor Park

Details

Scale
large

Identifier

Legal Name
Sandoz

Contact

Telephone
+44 7766295207

Award information

Award 1
Id
000987-2025-1
Title
Growth Hormone Daily Dose
Status
active

Suppliers

Supplier 1
Id
GB-FTS-58186
Name
Merck Serono Limited
Supplier 2
Id
GB-FTS-134791
Name
Novo Nordisk Ltd
Supplier 3
Id
GB-FTS-57454
Name
Pfizer Ltd
Supplier 4
Id
GB-FTS-95765
Name
Sandoz

Related lots

1
Award 2
Id
000987-2025-2
Title
Growth Hormone Long-Acting
Status
active

Suppliers

Supplier 1
Id
GB-FTS-134791
Name
Novo Nordisk Ltd
Supplier 2
Id
GB-FTS-57454
Name
Pfizer Ltd

Related lots

2

Contracts and changes

Entry 1
Id
000987-2025-1
Title
Growth Hormone Daily Dose
Status
active
Award ID
000987-2025-1
Date Signed
7 Jan 2025, 00:00

Value

Amount
15,300,000
Currency
GBP
Entry 2
Id
000987-2025-2
Title
Growth Hormone Long-Acting
Status
active
Award ID
000987-2025-2
Date Signed
7 Jan 2025, 00:00

Value

Amount
451,000
Currency
GBP

Recorded locations

  • Buyer location · Edinburgh · UKM · EH12 9EB · United Kingdom
  • Delivery location · UKM

Notice and amendment history

1 published notice version reviewed by ProcuraAxis.

1 VERSION
  1. ocds-h6vhtk-049ab4-2025-01-13T10:39:46Zcompiled ·